Alex Clarkson ACA, MCSI
Alex is an experienced corporate financier, investor and co-founder. Having spent his early years in Transaction Services and Due Diligence with PwC, he has since developed a broad range of advisory skills and trusted relationships across capital markets with a range of UK equity investors, private equity firms, high net worth individuals and banks. After PwC, Alex spent three years in Corporate Finance as part of the respected Brewin Dolphin Corporate Advisory and Broking team. Alex has been key to establishing and creating value in numerous companies including Zeus Group and Collagen Solutions.
+44 (0)161 240 7550
Michael Parkinson FCA
Michael has a broad range of corporate finance experience. Prior to joining Bamburgh Capital in 2016 Michael was CFO of an energy support services business, Cenergist. Before that he was a respected analyst and corporate stockbroker at Brewin Dolphin where he played a pivotal role in a number of successful IPOs and secondary fund raisings, he was ranked No 1 stock picker in Europe for the Support Services sector on two occasions. Michael started his career at PwC where he qualified as a chartered accountant and spent a number of years in the Transaction Services team.
+44 (0)191 249 7441
Murdo is an experienced corporate finance and investor relations professional. As a former Director of UK Investment Banking at Credit Suisse, he has a wealth of transaction and equity market experience. This experience is complemented by senior finance/investor relations roles, including as IR Director of The Sage Group PLC and IR Director and Head of Financial Planning & Analysis at Venator Materials PLC. He started his career with HSBC, joining their corporate finance graduate training programme, after graduating from St. Andrews University.
+44 (0)191 249 7442
Ed has a range of experience having started his career at GSA Capital Partners LLP, a quantitative hedge fund. Prior to joining Bamburgh Capital he spent 4 years at outsourced investment office Partners Capital LLP, where he worked on private and institutional client portfolios ranging from £5 million to over £1 billion, investing across all asset classes. Ed holds the Investment Management Certificate.
+44 (0)161 521 0317
Gabriel Schwalbe ACA
Gabriel joined the team from KPMG having spent 5 years in Deal Advisory across their M&A Advisory and Transaction Services functions, working on multi-sector domestic and international deals for private equity, corporate and owner-managed clients. He started his career in online retail management and business development roles in SMEs, in addition to internships at Barclays Corporate and Co op Group. Gabriel is ACA qualified and graduated from the University of Manchester with a first class degree in Economics and Finance.
+44 (0)161 521 0285
Chris Brinsmead CBE
Chris worked in the Pharmaceutical industry for over thirty years, holding executive leadership roles with ICI, Zeneca and Astrazeneca. He is a Non Executive director of several private and listed companies including UDG plc and The Wesleyan Assurance Society. He is Chairman at Proveca Ltd and a Member of Council at Imperial College. He co-founded Bamburgh Capital (renamed from Diagnostic Capital in 2016) with David Evans and Alex Clarkson in 2010. Chris was appointed a CBE in January 2015.
David Evans CA
David is an experienced Chairman and investor. He has a strong track record in taking companies through the IPO process and delivering significant value to shareholders. Most recently achieved successful exits for Sirigen (upto 4x value uplift), BBI (4x) and Scipac (exit achieved within 12 months of joining) as well as creating substantial uplifts in value during his tenure as Chairman for IDS (20x), Optibiotix Health (10x), DxS (10x), Scancell (5x) and Epistem (3x). He has considerable M&A experience including cross-border deals with over 20 transactions completed in the diagnostics/life sciences space. He is currently Chairman of Collagen Solutions plc and Omega Diagnostics plc. Previous roles include CEO of Axis-Shield plc and Chairman of Premaitha Health plc. Having co-founded Bamburgh Capital, David remains a shareholder and consultant.
Stuart Sharp LL.B
Stuart qualified as a solicitor at respected Scottish firm Brodies, WS, after reading Law at Edinburgh University. His exceptional 30 year career in the investment industry began in Scotland with Aberdeen Trust. He then joined Yorkshire-based Rensburg Fund Management (now Franklin Templeton Investments) and was a founding member of its successful funds team. As Investment Director there for over 10 years he was instrumental in growing funds from £30 million to over £1 billion. He has won numerous UK investment industry awards for performance particularly in the Equity Income and UK Smaller Company sectors. Following retirement from fund management in 2012, Stuart founded his own trusted consultancy to provide specialist investment counsel to Family Offices, High Net Worth Individuals and Charitable Foundations. He joined Bamburgh Capital as a consultant in 2017.
17 Marble Street,
+44 (0)161 240 7550
The Core, Bath Lane,
Newcastle Upon Tyne,
+44 (0)191 249 7441
© 2019 Bamburgh Capital Limited. All Rights Reserved. Registered in England and Wales No. 07155076. Registered Office: Bloc, 17 Marble Street, Manchester M2 3AW. Bamburgh Capital Limited is regulated and authorised by the Financial Conduct Authority.